Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Glucagon Like Peptide 1 (GLP1) Booster on Blood Glucose, HbA1c, Insulin, and GLP1 Levels, Body Weight and Body Fat in Overweight Adult Men and Women

NCT06333496 is registered in ClinicalTrials.gov with Alpine Biotech LLC as lead sponsor.

NCT NCT06333496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Glucagon Like Peptide 1 (GLP1) Booster on Blood Glucose, HbA1c, Insulin, and GLP1 Levels, Body Weight and Body Fat in Overweight Adult Men and Women
Lead sponsor
Alpine Biotech LLC
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2024
Completion date
May 8, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood sugar; high, fat burn, heart health markers, obesity, overweight and obesity